Literature DB >> 573001

Risk of angiosarcoma in workers exposed to vinyl chloride as predicted from studies in rats.

P J Gehring, P G Watanabe, C N Park.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 573001     DOI: 10.1016/0041-008x(79)90271-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  8 in total

1.  The problem of thresholds in chemical carcinogenesis some views on theoretical and practical aspects.

Authors:  R Preussmann
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

2.  Malignant tumors after chronic exposure to vinyl chloride.

Authors:  K H Emmerich; K Norpoth
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  Incorporation of biological information in cancer risk assessment: example--vinyl chloride.

Authors:  C W Chen; J N Blancato
Journal:  Cell Biol Toxicol       Date:  1989-12       Impact factor: 6.691

4.  Inhalation pharmacokinetics based on gas uptake studies. III. A pharmacokinetic assessment in man of "peak concentrations" of vinyl chloride.

Authors:  H M Bolt; J G Filser; A Buchter
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

Review 5.  Dose-response relationships for carcinogens: a review.

Authors:  L Zeise; R Wilson; E A Crouch
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

Review 6.  Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.

Authors:  D D Sumner; J T Stevens
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

7.  Dose-response analysis in animal studies: prediction of human responses.

Authors:  Y Alarie
Journal:  Environ Health Perspect       Date:  1981-12       Impact factor: 9.031

8.  Relevance of experimental studies to human risk.

Authors:  F K Dietz; J C Ramsey; P G Watanabe
Journal:  Environ Health Perspect       Date:  1983-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.